ARIEL GAVINO: Open Payments
NPI 1659531994 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 14 payments from 6 companies in 2025. Trend: 2023 $389 · 2024 $711 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $313 |
| Alkermes, Inc. | 5 | $216 |
| Indivior Inc. | 1 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: COBENFY, ARISTADA, SUBLOCADE, INGREZZA, MAVYRET, CAPLYTA.
Industry payments across CA — which companies pay providers there.
